Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution by Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri, Nicola Scichilone

“…Several studies comparing the triple therapy with the association of long-acting ß 2 agonist (LABA)/inhaled corticosteroid (ICS) or long-acting muscarinic antagonist (LAMA)/LABA reported improvement of lung function and quality of life. …”
Get full text